Nuvrumetinib
Nuvrumetinib (PAS-004) is a macrocyclic MEK inhibitor. Nuvrumetinib functionally inhibits MEK1/2, thereby suppressing pERK in tumors. Nuvrumetinib inhibits the proliferation of NRAS-mutant cancer cells. Nuvrumetinib can be used in studies related to NRASG12C-mutant solid tumors, neurofibromatosis type 1 (NF1), RASopathies and laminopathies.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3079099-31-0
- Formule: C19H18F3IN2O5S
- Masse moléculaire:570.32
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform MEK
More
Activité biologique
Description
IC50 & Target
[1]|
MEK1 |
MEK2 |
In Vitro
Chemical Information
-
CAS No. 3079099-31-0
-
Masse moléculaire 570.32
-
Formule C19H18F3IN2O5S
-
SMILES
O=S1(C2(C[C@H]([C@H](COC3=CC(F)=C(F)C(NC4=C(C=C(C=C4)I)F)=C3N1)O)O)CC2)=O
-
Synonyms
PAS-004
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)